it is the primary fuel for your beneficial gut bacteria
#Pharma #Obesity #Diabetes #GLP1 #Semaglutide #IndiaHealthcare #Generics #Innovation To view or add a comment, sign in Indias GLP-1 Market Just Got More Competitive - And More Accessible Abbotts partnership with Novo Nordisk to launch Extensor (semaglutide) as a second Ozempic brand in India signals a pivotal shift in the diabetes and obesity therapeutics landscape
We are offering the most advanced stem cell therapies for neural injuries and conditions, which have recently been shown to be useful for traumatic spine injury, traumatic brain injury, stroke, concussion, dementia, and even neurodegenerative diseases like Alzheimer's, Parkinson's, and ALS (5) (6) (7) (8) (9) (10) (11) (12a) (12b) (12c)
Giordano E, Visioli F
However, data to the contrary also exist and some small studies raised concerns that GLP1-RA use in CKD may be associated with more gastrointestinal side effects, hypoglycemic events, and loss of muscle mass 17,18